期刊文献+

携带GALV.fus基因的重组单纯疱疹病毒的组装、扩增及鉴定

Packaging,amplification and identification of recombinant tumor-selective type I herpes simplex virus vector containing GALV.fus gene
下载PDF
导出
摘要 目的:包装已成功构建的受Ⅰ型单纯疱疹病毒(HerpessimplexvirusⅠ,HSV-Ⅰ)晚期表达基因-UL38启动子调控的、嗜肿瘤单纯疱疹病毒介导的,长臂猿白血病病毒致融性外膜糖蛋白(Gibbon ape leukemia virus membrance fusion glycopratein,GALV.fus)基因质粒(HSV-UL38P-GALV.fus),无肿瘤特异性巨细胞病毒启动子(Cytomegalovirus promoter,CMVP)GALV.fus质粒(HSV-CMVP-GALV.fus),GALV.fus基因片段被增强型绿色荧光蛋白(Enhanced green fluorescent protein,EGFP)基因片段所取代的治疗对照质粒(HSV-CMVP-EGFP),分别命名为Synco-2、Synco-1、Baco-1。方法:扩增已成功构建的HSV-UL38P-GALV.fus、HSV-CMVP-GALV.fus、HSV-CMVP-EGFP质粒,然后分别在Vero细胞用脂质体转染、包装成重组嗜肿瘤单纯疱疹病毒。重组单纯疱疹病毒的扩增及纯化采用Vero细胞及氯化铯纯化常规方法,病毒滴度测定采用TCID50法。Synco-1、Synco-2病毒感染肝癌细胞株HepG2,分别提取受染肝癌细胞HepG2的总RNA,以RT-PCR的方法鉴定GALV.fus基因的表达。结果:成功包装了3种重组单纯疱疹病毒Baco-1、Synco-1和Synco-2,按需要在Vero细胞内扩增后以氯化铯密度梯度离心法进行纯化,TCID50法测得病毒滴度分别为3×1010 pfu/ml1,×1011 pfu/ml和4×1010 pfu/ml。受染肝癌细胞株HepG2中以RT-PCR法检测到GALV.fus基因的表达。结论:成功包装、扩增及纯化3种重组单纯疱疹病毒,受染肝癌细胞株HepG2中以RT-PCR法检测到GALV.fus基因的表达。 Objective:Package of constructed recombinant tumor-selective type I Herpes simplex virus vector plasmid containing UL38 and CMV promoter and GALV.fus gene (HSV-UL38P-GALV.fus、HSV-CMVP-GALV.fus),GALV.fus gene was replaced by EGFP in control plasmid (HSV-CMVP-EGFP). The three recombinant viruses were named Synco-2、Synco-1 and Baco-1 respectively。Methods: At first the three constructed plasmids were amplificated in coliform bacterium and transfected into Vero cells by using lipofectamine respectively. Then,these three recombinant type I Herpes simplex viruses were propagated in Vero cells and purified by cesium chloride density purification,titrated by TCID50 method. In the end,Total RNA was extracted from the HepG2 cells which were transfected by Synco-1 and Synco-2 and GALV.fus mRNA was detected by RT-PCR. Results:The three recombinant HSV-1 vectors were packaged successfully,which were propagated in Vero cells and purified by cesium chloride density purification,titrated by TCID50 method. The titre of Baco-1、Synco-1 and Synco-2 were 3×10 10 pfu/ml,1×10 11 pfu/ml and 4×10 10 pfu/ml respectively.GALV.fus gene were identified in the infected HepG2 cells. Conclusion:We packed,amplificated and purified Recombinant HSV-I virus successfully and the expression of GALV.fus gene was identified in the infected HepG2 cells by RT-PCR.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第10期1471-1474,共4页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:30471984) 重庆市卫生局资助项目(编号:06-2-001 07-2-116 2010-2-127)
关键词 I型单纯疱疹病毒 长臂猿白血病病毒致融性外膜糖蛋白 基因重组 Type I Herpes simplexvirus Gibbon ape leukemia virus membrane fusion glycoprotein Gene recombination
  • 相关文献

参考文献10

  • 1McNeish I A, Bell S J ,Lemoine N R. Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes[J].Gene Therapy ,2004,11 (6) : 497-503.
  • 2Faiih S A,Sweet T J,Bailey E,et al.Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells[J].Antiviral Res,2006, 72( 3 ) : 242-251.
  • 3Fu X P, Feng M,Tao L H, et al. A strict late viral promoter is a strong tumor-specific promoter in the context of an oncolytic herpes simplex virus [J].Gene Ther, 2003,10( 17 ) : 1458-1466.
  • 4Higuehi H,Bronk S F,Bateman A,et al. Viral fusogenic membrane glycoprotein expression cauls syncytia formation with bit,energetic cell death : implications for gene therapy[JJ.Cancer Res, 2000, 60 (22): 6396- 6402.
  • 5斯佩克特 D L,戈德曼 R D,莱因万德 L A.细胞试验指南[M].北京:科学出版社,2001:830-831.
  • 6Greenstone H L,Nieland J D,Visser K E,et al. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPVI6 tumormodel[J].Medical Sci, 1998,95(4):1800- 1805.
  • 7Boviatsis E J,Scharf J M, Chase M, et al.Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase[J].Gene Ther, 1994,1 ( 5 ): 323-331.
  • 8Toda M, Martuza R L,Kojima H,et al.ln Situ Cancer Vaccination: An IL-12 Defective Vector/Replication-Competent Herpes Simplex Virus Combination Induces Local and Systemic Antitumor Activity[J].J lmmunol, 1998,5(160) : 4457-4464.
  • 9Jr Sainz B, Halford W P.Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1 [J].J Virol, 2002,76(22 ) : 11541- 11550.
  • 10Guyader F L,Loisy F,Atmar R L,et al.Norwalk virus-specific binding to oyster digestive tissues[J].Emerg Infect Dis,2006,12(6) :931- 936.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部